These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12673715)

  • 41. Age-specific risk of incident prostate cancer and risk of death from prostate cancer defined by the number of affected family members.
    Brandt A; Bermejo JL; Sundquist J; Hemminki K
    Eur Urol; 2010 Aug; 58(2):275-80. PubMed ID: 20171779
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An epidemiological reappraisal of the familial aggregation of prostate cancer: a meta-analysis.
    Kiciński M; Vangronsveld J; Nawrot TS
    PLoS One; 2011; 6(10):e27130. PubMed ID: 22073129
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Family history facilitates the early diagnosis of prostate carcinoma.
    Walsh PC; Partin AW
    Cancer; 1997 Nov; 80(9):1871-4. PubMed ID: 9351562
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Family history and the risk of prostate cancer.
    Steinberg GD; Carter BS; Beaty TH; Childs B; Walsh PC
    Prostate; 1990; 17(4):337-47. PubMed ID: 2251225
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk of prostate cancer associated with a family history in an era of rapid increase in prostate cancer diagnosis (Australia).
    Staples MP; Giles GG; English DR; McCredie MR; Severi G; Cui JS; Hopper JL
    Cancer Causes Control; 2003 Mar; 14(2):161-6. PubMed ID: 12749721
    [TBL] [Abstract][Full Text] [Related]  

  • 46. First-degree family history of breast cancer is associated with prostate cancer risk: a systematic review and meta-analysis.
    Ren ZJ; Cao DH; Zhang Q; Ren PW; Liu LR; Wei Q; Wei WR; Dong Q
    BMC Cancer; 2019 Sep; 19(1):871. PubMed ID: 31477094
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relative risk of prostate cancer for men with affected relatives: systematic review and meta-analysis.
    Bruner DW; Moore D; Parlanti A; Dorgan J; Engstrom P
    Int J Cancer; 2003 Dec; 107(5):797-803. PubMed ID: 14566830
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A systematic review and meta-analysis of familial prostate cancer risk.
    Johns LE; Houlston RS
    BJU Int; 2003 Jun; 91(9):789-94. PubMed ID: 12780833
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Familial risk and familial survival in prostate cancer.
    Hemminki K
    World J Urol; 2012 Apr; 30(2):143-8. PubMed ID: 22116601
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk for incident and fatal prostate cancer in men with a family history of any incident and fatal cancer.
    Brandt A; Sundquist J; Hemminki K
    Ann Oncol; 2012 Jan; 23(1):251-256. PubMed ID: 21467126
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Adenocarcinoma of the prostate. Familial risk in Icelandic males.].
    Jonsson E; Olafsdottir G; Sigvaldason H; Tulinius H
    Laeknabladid; 1999 Sep; 85(9):708-10. PubMed ID: 19439800
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Familial study of prostate cancer in Jamaica.
    Glover FE; Coffey DS; Douglas LL; Russell H; Cadigan M; Tulloch T; Wedderburn K; Wan RL; Baker TD; Walsh PC
    Urology; 1998 Sep; 52(3):441-3. PubMed ID: 9730457
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Familial patterns of prostate cancer: a case-control analysis.
    Spitz MR; Currier RD; Fueger JJ; Babaian RJ; Newell GR
    J Urol; 1991 Nov; 146(5):1305-7. PubMed ID: 1942282
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Familial aspects of prostatic carcinoma. Personal experience and review of the literature].
    Magno C; Inferrera A; Crea G; Di Bernardo N; Famulari C
    Minerva Urol Nefrol; 1995 Sep; 47(3):113-5. PubMed ID: 8815547
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Familial recurrence risk with varying amount of family history.
    Schaid DJ; McDonnell SK; Thibodeau SN
    Genet Epidemiol; 2019 Jun; 43(4):440-448. PubMed ID: 30740785
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Familial prostate cancer research: meaningfulness of hereditary criteria in view of demographic change].
    Herkommer K; Heimpel M; Gschwend JE
    Urologe A; 2014 Dec; 53(12):1779-85. PubMed ID: 25214313
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of a Changing Population Structure and Clustering of Cancer in Prostate Cancer Patients Depending on a First-Degree Family History.
    Meissner VH; Bittner R; Kron M; Schiele S; Schulwitz H; Gschwend JE; Herkommer K
    Urol Int; 2020; 104(3-4):222-229. PubMed ID: 31865349
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Familial prostate cancer.
    Stanford JL; Ostrander EA
    Epidemiol Rev; 2001; 23(1):19-23. PubMed ID: 11588848
    [No Abstract]   [Full Text] [Related]  

  • 59. Reported family history of cancer in 1,271 prostate cancer cases and 1,909 controls.
    Mettlin C; Natarajan N; Huben R; Raghavan D
    Urol Oncol; 1995; 1(6):240-5. PubMed ID: 21224125
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mendelian inheritance of familial prostate cancer.
    Carter BS; Beaty TH; Steinberg GD; Childs B; Walsh PC
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3367-71. PubMed ID: 1565627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.